Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Stentys
  6. Summary
    STNT   FR0010949404

STENTYS

(STNT)
 SummaryQuotesChartsNewsCompanyFinancials 
Estimated financial data (e)
Sales 2018 8,89 M 10,4 M 10,4 M
Net income 2018 -5,40 M -6,28 M -6,28 M
Net cash position 2018 9,71 M 11,3 M 11,3 M
P/E ratio 2018 -2,01x
Yield 2018 -
Sales 2019 8,32 M 9,68 M 9,68 M
Net income 2019 -17,6 M -20,5 M -20,5 M
Net cash position 2019 7,75 M 9,02 M 9,02 M
P/E ratio 2019 -0,70x
Yield 2019 -
Capitalization 14,0 M 16,8 M 16,3 M
EV / Sales 2018 0,39x
EV / Sales 2019 0,75x
Nbr of Employees 26
Free-Float 99,9%
More Financials
Company
Stentys SA is a French-based company specialized in the development of a new generation of stents for the treatment of acute myocardial infarction or coronary artery disease. It's main product STENTYS Stent, self-expanding coronary bare-metal stent system, is indicated for the treatment of Acute Coronary Syndrome. The Company's institutional shareholders are Sofinnova Partners, Credit Agricole Private Equity and... 
More about the company
All news about STENTYS
2020Stentys S.A. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
2020STENTYS : Financial Information for the First Quarter Of 2020
BU
2020STENTYS S.A. Announces Revenue Results for the First Quarter Of 2020
CI
2020STENTYS : Financial Information for the First Quarter of 2020
PU
2020STENTYS : 1st quarter earnings
CO
2020STENTYS : 2019 Annual Results
PU
2020STENTYS : Annual results
CO
2019STENTYS : Convening of another Combined General Meeting on November 14, 2019
PU
2019STENTYS : 2019 half-year results
PU
2019Stentys Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2019
CI
2019STENTYS : Half-year results
CO
2019STENTYS : Financial Information for the Third Quarter of 2019
PU
2019STENTYS : 3rd quarter earnings
CO
2019STENTYS : Financial Information for the First Half of 2019
PU
2019STENTYS : 2nd quarter earnings
CO
More news
News in other languages on STENTYS
07/23PLONGÉE DANS LE BUSINESS DES OCABSA : Interview de Pierre Vannineuse
03/24EN DIRECT DES MARCHES : Carrefour, EssilorLuxottica, Valneva, Tesla, Microsoft, Leonardo, ..
03/23STENTYS : L'Assemblée générale de STENTYS décide la dissolution anticipée de la Société
03/06STENTYS :  Convocation à une nouvelle Assemblée générale mixte le 23 mars 2021
03/03EN DIRECT DES MARCHES  : Danone, Schneider, Orange, CNP Assurances, Lumibird, Intel, Merck..
More news
Chart STENTYS
Duration : Period :
Stentys Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Michel Darnaud Chairman & Chief Executive Officer
André Lerebours Chief Financial Officer & Deputy CEO
Pierre Brégeard Chief Technology Officer
Olivier Pierron Chief Operating Officer
Marie Meynadier Independent Director
Sector and Competitors
1st jan.Capi. (M$)
STENTYS0.00%17
ABBOTT LABORATORIES15.74%224 651
MEDTRONIC PLC5.08%165 656
BECTON, DICKINSON AND COMPANY-1.25%70 962
HOYA CORPORATION21.65%56 316
DEXCOM, INC.53.24%54 815